Tamtam Try Tamtam free
Spire Healthcare Group plc logo

Spire Healthcare Group plc account plan

UK Private Healthcare Services

At a glance

Spire Healthcare is a UK independent hospital and primary care group: 38 hospitals, £1,579.8m FY2025 revenue, 17,800 colleagues.

Spire Healthcare Group plc is a large independent UK healthcare group operating across England, Wales and Scotland, with 38 hospitals, over 60 clinics and almost 100 clinical sites in primary care. It cared for 1.36m+ people in 2025, employs 17,800 colleagues and works with over 8,800 consultants. Private patients were 65% of group revenue (PMI 43%, self-pay 21%) and the NHS 31%. FY2025 revenue was £1,579.8m (+4.5%), adjusted EBITDA £268.6m and operating profit £122.6m. A Toscafund-led consortium has made a recommended final offer for the company.

Business units

Strategic priorities

Transformation savings
Centralise, standardise, digitalise and enable AI: £30m of new savings in 2025 and a savings target above £30m for 2026 to at least offset the Q1 NHS shortfall.
Private payer growth
Mid to high single digit private revenue growth in 2026, supported by record brand awareness and AI-optimised local self-pay pricing.
Website and CRM
A new website and CRM integrating all patient types across primary and secondary care is a named 2026 priority.
Scale primary care
Take primary care from about £10 million of EBITDA to £40 million in the medium term through organic growth, new NHS contracts, new clinics and small M&A, with no more than £50 million of capex.
Capex discipline
Capex reduced about 30% to £78.5m in 2026 as the estate is well invested; only a few capex-light clinics are planned.

Latest results

In H1 2026 (six months to 30 June 2026) revenue was £792.7m, down 0.8% comparable, and adjusted EBITDA fell 16.6% to £112.4m (14.2% margin), with a statutory loss before tax of £14.8m. Self-pay revenue rose 4.5% and PMI 3.1%, but NHS revenue fell 14.3% (Q1 down 24.9%, Q2 down 3.2% after commissioning plans reset in April 2026). Adjusted free cash flow rose 35.3% to £20.7m, net bank debt was £337.8m (leverage 2.4x) and no interim dividend was paid. FY26 adjusted EBITDA is targeted broadly in line with FY25.

Investments and deals

Patient support centres
Three centres in Brentwood, Cardiff and Seaham absorbed administration for 36 hospitals and lifted call answer rates above 95% from 60%.
Robotics and AI imaging
Over 30 robots installed and AI on MRI scanners in 21 hospitals halving scan times.
Primary care acquisitions
Acorn Health and Physiolistic were acquired at mid-single-digit multiples, adding to £8 million of new annual contract revenue including John Lewis Partnership.
Bupa partnership
A new four-year strategic partnership with Bupa covering cancer specialist centres, MSK rapid access and a gynaecology specialist centre.

Challenges and risks

NHS commissioning slowdown
NHS budgetary restrictions cut commissioning to the independent sector from late 2025; NHS revenue fell 14.3% in H1 2026 and the provisional 2026 NHS tariff is close to 0%.
Labour cost inflation
National Insurance and National Minimum Wage increases weigh on costs while the NHS tariff uplift falls short of inflation.
Ownership uncertainty
The strategic review led to a recommended final offer from a Toscafund-led consortium, and the H1 2026 report carries a material going-concern uncertainty disclosure.
Leadership transition
Justin Ash retired as CEO on 5 September 2026; Sir David Sloman is Interim CEO.
PMI volume pressure
PMI volumes dipped as insurers tighten claims and younger insured members use primary care.

What leadership says

“the biggest year of change yet for our business”

Justin Ash, Chief Executive Officer (retired 5 September 2026) · Full year 2025 results call, 5 March 2026

“the business we think is in the best position it has ever been in to navigate a very dynamic environment”

Justin Ash, Chief Executive Officer (retired 5 September 2026) · Half year 2025 results call, 31 July 2025

Where a supplier can help

CRM and digital front door
The new website and CRM integrating all patient types across primary and secondary care is a named priority, a direct opening for CRM, web and patient-engagement suppliers.
Automation behind transformation savings
A savings target above £30m for 2026 and the centralise-digitalise-AI programme fit P2P automation, AI scheduling and contact-centre tooling.
Employer health services
Growth in workplace health and occupational health under Spire for Business suits partners selling to employers or into occupational health workflows.
Cyber security
Cyber security is one of the 15 principal risks as digital platforms expand, supporting security offers.

Tamtam's reading of the priorities and challenges above, not the company's own words.

Selling to companies like Spire Healthcare Group plc?

Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.

Find similar companies

Key documents

Read in full by Tamtam; each summary links to the document itself.

Questions about Spire Healthcare Group plc

What does Spire Healthcare do?

Spire runs 38 private hospitals and over 60 clinics in England, Wales and Scotland, plus primary care services such as talking therapies, physiotherapy, occupational health and GP care, for insured, self-pay and NHS patients.

What is Spire Healthcare's revenue?

FY2025 revenue was £1,579.8m with adjusted EBITDA of £268.6m. H1 2026 revenue was £792.7m.

How many employees does Spire Healthcare have?

Spire employs 17,800 colleagues and works with over 8,800 consultants.

Who leads Spire Healthcare?

Sir David Sloman is Interim CEO since Justin Ash retired on 5 September 2026, and Debbie White is Chair.

Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)